Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Steven T. Harris · JAMA · 1999 · 2.5K citations

Medicine, Endocrinology, Bone Augmentation +16

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Medicine, Endocrinology, Bone Metabolism +14

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

S. R. Cummings · JAMA · 1998 · 2.3K citations

Medicine, Endocrinology, Bone Augmentation +16

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Jean‐Yves Reginster, H. W. Minne, O. H. Sørensen et al. · Osteoporosis International · 2000 · 1.6K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14